SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Rocon who wrote (12481)8/2/1998 3:27:00 PM
From: EyeDrMike  Respond to of 23519
 
i believe they stated yr2000 approval for alibra, in the last CC

mike



To: Rocon who wrote (12481)8/2/1998 4:02:00 PM
From: AlienTech  Respond to of 23519
 
Alibra is supposed to be available in the first part of 99 so I would think they would already be going through the motions and would know something by end of the year, at which time they can sell the company and Leyland and chums can retire to their penis shaped bath tub.

Is the drugs available after the finish Phase3 trials? Since some of the results are already from P3 why would it take 2 more years for approval?



To: Rocon who wrote (12481)8/2/1998 4:21:00 PM
From: DAVID  Read Replies (1) | Respond to of 23519
 
<< Do you or anyone on this thread have a realistic timetable for when Vivus might receive FDA approval for Alibra? >>

Ron,

When I was at the annual meeting, way back when, Wilson indicated Alibra should be on the market in the first part of 2000. If that time table is still accurate, I do not know.

If there is a more current answer by anyone, please post the new date.

DAVID


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News